Aditxt, Inc. Shareholders' Equity
Aditxt, Inc. (ADTX) had Shareholders' Equity of -$33.28 million as of 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-05-20
- 2026-03-31: Stockholders' Equity Attributable to Parent -$33.28M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $5.61M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$7.73M.
- 2025-06-30: Stockholders' Equity Attributable to Parent $12.96M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-03-31 | -$33.28M 10-Q · filed 2026-05-20 | |
| 2025-12-31 | $5.61M 10-Q · filed 2026-05-20 | |
| 2025-09-30 | -$7.73M 10-Q · filed 2025-11-18 | |
| 2025-06-30 | $12.96M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $16.59M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $1.67M 10-K · filed 2026-03-31 | $496.58K 10-K · filed 2025-03-31 |
| 2024-09-30 | $4.71M 10-Q · filed 2024-11-18 | |
| 2024-06-30 | $6.57M 10-Q · filed 2024-08-19 | |
| 2024-03-31 | $9.93M 10-Q · filed 2024-05-20 | |
| 2023-12-31 | $16.06M 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$4.22M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | -$3.87M 10-Q · filed 2023-11-14 | |
| 2023-03-31 | $68.07K 10-Q · filed 2023-11-14 | |
| 2022-12-31 | $5.21M 10-K · filed 2024-04-16 | |
| 2022-09-30 | $12.69M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $1.36M 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $4.72M 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $10.18M 10-Q · filed 2023-11-14 | |
| 2021-09-30 | $12.97M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $5.96M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $11.37M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $11.01M 10-K · filed 2023-04-17 | |
| 2020-09-30 | $13.75M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | -$3.71M 10-Q · filed 2021-11-15 | |
| 2020-03-31 | -$3.52M 10-Q · filed 2021-11-15 | |
| 2019-12-31 | -$2.85M 10-K · filed 2022-03-31 | |
| 2019-09-30 | -$2.66M 10-Q · filed 2020-11-13 | |
| 2019-06-30 | -$2.33M 10-Q · filed 2020-11-13 | |
| 2019-03-31 | -$1.81M 10-Q · filed 2020-11-13 | |
| 2018-12-31 | -$1.54M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |